{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:05Z","timestamp":1792169165727,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      In the Women\u2019s Health Initiative (WHI) Dietary Modification (DM) randomized trial, a low-fat dietary pattern intervention reduced breast cancer mortality (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02). Higher dietary advanced glycation end-products (dAGE) may be associated with higher breast cancer incidence. In this report, we examined whether the WHI dietary intervention influenced dAGE consumption.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Of 48,835 postmenopausal women randomized (40:60) to dietary intervention versus usual diet comparison, 40,209 had food frequency questionnaires at baseline, and serially through 5\u20137 years, which were used to estimate dAGE scores (kilo Unit\/1000 kilocalories [kU\/1000\u2009kcal]) using a commonly referenced database. Multivariate regressions with repeated dAGE measures were examined by randomization group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline mean dAGE scores were similar for intervention (7542\u2009kU\/1000\u2009kcal, standard deviation (SD)\u2009=\u2009912) and comparison (7514\u2009kU\/1000\u2009kcal, SD\u2009=\u2009917) groups. Through 5\u20137 years, dAGE scores were persistently lower in intervention versus comparison groups (mean range 5361\u20136236\u2009kU\/1000\u2009kcal versus 7159\u20137669\u2009kU\/1000\u2009kcal (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The WHI low-fat dietary pattern intervention substantially reduced dAGE consumption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>NCT00000611; Date: 10\/28\/1999.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03514-x","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:49:37Z","timestamp":1785214177000},"page":"1424-1429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-fat dietary pattern and dietary advanced glycation end-products intake: a secondary analysis of the Women\u2019s Health Initiative randomized trial"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-4400","authenticated-orcid":false,"given":"Margaret S.","family":"Pichardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca P.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-2566","authenticated-orcid":false,"given":"Kathy","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mace","family":"Coday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-1830","authenticated-orcid":false,"given":"Su Yon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Snetselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian L.","family":"Neuhouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3201-9537","authenticated-orcid":false,"given":"Susan E.","family":"Steck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-7150","authenticated-orcid":false,"given":"Fred K.","family":"Tabung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazmus","family":"Saquib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9426-7595","authenticated-orcid":false,"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan T.","family":"Chlebowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3514_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0140-6736(03)13950-5","volume":"362","author":"RL Prentice","year":"2003","unstructured":"Prentice RL. Dietary assessment and the reliability of nutritional epidemiology reports. Lancet. 2003;362:182\u20133.","journal-title":"Lancet"},{"key":"3514_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.19.00435","volume":"38","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, et al. Dietary modification and breast cancer mortality: long-term follow-up of the Women\u2019s Health Initiative randomized trial. J Clin Oncol. 2020;38:1419\u201328.","journal-title":"J Clin Oncol"},{"key":"3514_CR3","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.metabol.2012.04.007","volume":"61","author":"ML Neuhouser","year":"2012","unstructured":"Neuhouser ML, Howard B, Lu J, Tinker LF, Van Horn L, Caan B, et al. A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women\u2019s Health Initiative. Metabolism. 2012;61:1572\u201381.","journal-title":"Metabolism"},{"key":"3514_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41416-021-01379-w","volume":"125","author":"K Pan","year":"2021","unstructured":"Pan K, Aragaki AK, Neuhouser ML, Simon MS, Luo J, Caan B, et al. Low-fat dietary pattern and breast cancer mortality by metabolic syndrome components: a secondary analysis of the Women\u2019s Health Initiative (WHI) randomised trial. Br J Cancer. 2021;125:372\u20139.","journal-title":"Br J Cancer"},{"key":"3514_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","volume":"110","author":"J Uribarri","year":"2010","unstructured":"Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110:911\u201316 e12.","journal-title":"J Am Diet Assoc"},{"key":"3514_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900934","volume":"65","author":"D Sergi","year":"2021","unstructured":"Sergi D, Boulestin H, Campbell FM, Williams LM. The role of dietary advanced glycation end products in metabolic dysfunction. Mol Nutr Food Res. 2021;65:e1900934.","journal-title":"Mol Nutr Food Res"},{"key":"3514_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1017\/S0954422420000104","volume":"33","author":"ME Garay-Sevilla","year":"2020","unstructured":"Garay-Sevilla ME, Beeri MS, de la Maza MP, Rojas A, Salazar-Villanea S, Uribarri J. The potential role of dietary advanced glycation endproducts in the development of chronic non-infectious diseases: a narrative review. Nutr Res Rev. 2020;33:298\u2013311.","journal-title":"Nutr Res Rev"},{"key":"3514_CR8","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/advances\/nmab072","volume":"12","author":"E Sharifi-Zahabi","year":"2021","unstructured":"Sharifi-Zahabi E, Sharafabad FH, Abdollahzad H, Malekahmadi M, Rad NB. Circulating advanced glycation end products and their soluble receptors in relation to all-cause and cardiovascular mortality: a systematic review and meta-analysis of prospective observational studies. Adv Nutr. 2021;12:2157\u201371.","journal-title":"Adv Nutr"},{"key":"3514_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canep.2016.04.004","volume":"42","author":"L Chen","year":"2016","unstructured":"Chen L, Duan Z, Tinker L, Sangi-Haghpeykar H, Strickler H, Ho GY, et al. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. Cancer Epidemiol. 2016;42:115\u201323.","journal-title":"Cancer Epidemiol"},{"key":"3514_CR10","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/cam4.1426","volume":"7","author":"DL White","year":"2018","unstructured":"White DL, Hoogeveen RC, Chen L, Richardson P, Ravishankar M, Shah P, et al. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med. 2018;7:2180\u201391.","journal-title":"Cancer Med"},{"key":"3514_CR11","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/cas.15455","volume":"113","author":"K Wada","year":"2022","unstructured":"Wada K, Nakashima Y, Yamakawa M, Hori A, Seishima M, Tanabashi S, et al. Dietary advanced glycation end products and cancer risk in Japan: from the Takayama study. Cancer Sci. 2022;113:2839\u201348.","journal-title":"Cancer Sci"},{"key":"3514_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1158\/1940-6207.CAPR-19-0457","volume":"13","author":"OO Omofuma","year":"2020","unstructured":"Omofuma OO, Turner DP, Peterson LL, Merchant AT, Zhang J, Steck SE. Dietary advanced glycation end-products (AGE) and risk of breast cancer in the prostate, lung, colorectal and ovarian cancer screening trial (PLCO). Cancer Prev Res. 2020;13:601\u201310.","journal-title":"Cancer Prev Res"},{"key":"3514_CR13","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/cncr.32798","volume":"126","author":"LL Peterson","year":"2020","unstructured":"Peterson LL, Park S, Park Y, Colditz GA, Anbardar N, Turner DP. Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2020;126:2648\u201357.","journal-title":"Cancer"},{"key":"3514_CR14","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S1047-2797(03)00043-7","volume":"13","author":"GL Anderson","year":"2003","unstructured":"Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the Women\u2019s Health Initiative study design. Ann Epidemiol. 2003;13:S5\u201317.","journal-title":"Ann Epidemiol"},{"key":"3514_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.295.6.629","volume":"295","author":"RL Prentice","year":"2006","unstructured":"Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women\u2019s Health Initiative randomized controlled dietary modification trial. JAMA. 2006;295:629\u201342.","journal-title":"JAMA"},{"key":"3514_CR16","unstructured":"ClinicalTrials.gov. Women\u2019s Health Initiative (WHI) [Available from: https:\/\/clinicaltrials.gov\/study\/NCT00000611"},{"key":"3514_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1047-2797(98)00055-6","volume":"9","author":"RE Patterson","year":"1999","unstructured":"Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women\u2019s Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9:178\u201387.","journal-title":"Ann Epidemiol"},{"key":"3514_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jnci\/djx117","volume":"110","author":"L Jiao","year":"2018","unstructured":"Jiao L, Chen L, White DL, Tinker L, Chlebowski RT, Van Horn LV, et al. Low-fat dietary pattern and pancreatic cancer risk in the Women\u2019s Health Initiative dietary modification randomized controlled trial. J Natl Cancer Inst. 2018;110:49\u201356.","journal-title":"J Natl Cancer Inst"},{"key":"3514_CR19","doi-asserted-by":"publisher","first-page":"1220S","DOI":"10.1093\/ajcn\/65.4.1220S","volume":"65","author":"WC Willett","year":"1997","unstructured":"Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S\u20138S. discussion 9S\u201331S.","journal-title":"Am J Clin Nutr"},{"key":"3514_CR20","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1158\/1055-9965.EPI-21-0610","volume":"30","author":"OO Omofuma","year":"2021","unstructured":"Omofuma OO, Peterson LL, Turner DP, Merchant AT, Zhang J, Thomson CA, et al. Dietary advanced glycation end-products and mortality after breast cancer in the Women\u2019s Health Initiative. Cancer Epidemiol Biomark. Prev. 2021;30:2217\u201326.","journal-title":"Cancer Epidemiol Biomark. Prev"},{"key":"3514_CR21","doi-asserted-by":"publisher","first-page":"e181212","DOI":"10.1001\/jamaoncol.2018.1212","volume":"4","author":"RT Chlebowski","year":"2018","unstructured":"Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, et al. Association of low-fat dietary pattern with breast cancer overall survival: a secondary analysis of the Women\u2019s Health Initiative randomized clinical trial. JAMA Oncol. 2018;4:e181212.","journal-title":"JAMA Oncol"},{"key":"3514_CR22","first-page":"454","volume":"103","author":"RE Patterson","year":"2003","unstructured":"Patterson RE, Kristal A, Rodabough R, Caan B, Lillington L, Mossavar-Rahmani Y, et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women\u2019s Health Initiative. J Am Diet Assoc. 2003;103:454\u201360.","journal-title":"J Am Diet Assoc"},{"key":"3514_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.295.1.39","volume":"295","author":"BV Howard","year":"2006","unstructured":"Howard BV, Manson JE, Stefanick ML, Beresford SA, Frank G, Jones B, et al. Low-fat dietary pattern and weight change over 7 years: the Women\u2019s Health Initiative dietary modification trial. JAMA. 2006;295:39\u201349.","journal-title":"JAMA"},{"key":"3514_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/cdn\/nzaa021","volume":"4","author":"L Van Horn","year":"2020","unstructured":"Van Horn L, Aragaki AK, Howard BV, Allison MA, Isasi CR, Manson JE, et al. Eating pattern response to a low-fat diet intervention and cardiovascular outcomes in normotensive women: the Women\u2019s Health Initiative. Curr Dev Nutr. 2020;4:nzaa021.","journal-title":"Curr Dev Nutr"},{"key":"3514_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.diabet.2012.01.003","volume":"38","author":"N Lin","year":"2012","unstructured":"Lin N, Zhang H, Su Q. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress. Diabetes Metab. 2012;38:250\u20137.","journal-title":"Diabetes Metab"},{"key":"3514_CR26","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1007\/s00394-019-02129-8","volume":"59","author":"R Cordova","year":"2020","unstructured":"Cordova R, Knaze V, Viallon V, Rust P, Schalkwijk CG, Weiderpass E, et al. Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults. Eur J Nutr. 2020;59:2893\u2013904.","journal-title":"Eur J Nutr"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03514-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03514-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03514-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:29Z","timestamp":1792166249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03514-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11,5]]}},"alternative-id":["3514"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03514-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The WHI study was approved at participating clinical centers, and all participants gave written informed consent. This study was performed in accordance with the relevant guidelines and regulations set forth by the WHI study and affiliated clinical centers.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors report no conflicts of interest with the following exceptions: RTC reported being a consultant for Pfizer and UpToDate.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}